Glycation End Products, Advanced
"Glycation End Products, Advanced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of compounds derived from rearrangements, oxidation, and cross-linking reactions that follow from non-enzymatic glycation of amino groups in proteins. They are also know as Maillard products. Their accumulation in vivo accelerates under hyperglycemic, oxidative, or inflammatory conditions. Heat also accelerates the formation of advanced glycation end products (AGEs) such seen with the browning of food during cooking under or over high heat.
| Descriptor ID |
D017127
|
| MeSH Number(s) |
D12.776.643.500
|
| Concept/Terms |
Glycation End Products, Advanced- Glycation End Products, Advanced
- Maillard Reaction End Products
- Maillard Reaction Products
- Products, Maillard Reaction
- Reaction Products, Maillard
- Advanced Maillard Reaction End Products
- Glycation Endproducts, Advanced
- Endproducts, Advanced Glycation
- Glycosylation End Products, Advanced
- Advanced Glycosylation Endproducts
- Endproducts, Advanced Glycosylation
- Glycosylation Endproducts, Advanced
- Advanced Glycation End Products
- Advanced Glycosylation End Products
- Maillard Products
- Products, Maillard
- Advanced Glycation Endproducts
|
Below are MeSH descriptors whose meaning is more general than "Glycation End Products, Advanced".
Below are MeSH descriptors whose meaning is more specific than "Glycation End Products, Advanced".
This graph shows the total number of publications written about "Glycation End Products, Advanced" by people in this website by year, and whether "Glycation End Products, Advanced" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2016 | 1 | 2 | 3 |
| 2017 | 7 | 10 | 17 |
| 2018 | 7 | 4 | 11 |
| 2019 | 4 | 6 | 10 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Glycation End Products, Advanced" by people in Profiles.
-
Importance of Lung Epithelial Injury in COVID-19-associated Acute Respiratory Distress Syndrome: Value of Plasma Soluble Receptor for Advanced Glycation End-Products. Am J Respir Crit Care Med. 2021 08 01; 204(3):359-362.
-
Dietary advanced glycation end-products elicit toxicological effects by disrupting gut microbiome and immune homeostasis. J Immunotoxicol. 2021 07 24; 18(1):93-104.
-
Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis. Int Immunopharmacol. 2021 Sep; 98:107806.
-
Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison? World J Gastroenterol. 2021 May 21; 27(19):2270-2280.
-
Distinct temporal characteristics of circulating alveolar epithelial and endothelial injury markers in ARDS with COVID-19. Crit Care. 2021 05 17; 25(1):169.
-
Pro-oxidant and pro-inflammatory effects of glycated albumin on cardiomyocytes. Free Radic Biol Med. 2019 11 20; 144:245-255.
-
Acute, genetic and sub-chronic toxicities of flaxseed derived Maillard reaction products. Food Chem Toxicol. 2019 Sep; 131:110580.
-
Liquiritigenin Reduces Blood Glucose Level and Bone Adverse Effects in Hyperglycemic Adult Zebrafish. Nutrients. 2019 May 09; 11(5).
-
Demethoxycurcumin: A naturally occurring curcumin analogue for treating non-cancerous diseases. J Cell Physiol. 2019 11; 234(11):19320-19330.
-
Inflammatory effects of in vivo glycated albumin from cardiovascular patients. Biomed Pharmacother. 2019 May; 113:108763.